Roche Products Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyWelwyn Garden CityNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPXCG-4172-CHYMCompanies House00100674 ↗ · Active

Where they win
i

108 awards (105 for a named lot, 97%, 3 for a whole procedure with no lot named) · top CPV classes, shares of all 108 awards. An award may cover more than one class.

3360 Pharmaceutical products108 awards · 100% · 105 awards naming a lot + 3 whole-procedure awards
Attributable award value
i
£153mOn 10 of 108 award records; the five largest make 97%. Largest rows below.
Typical attributable award
i
£4.5m middle valuerobust · n=10

Where their buyers are
i

ITL1 region of the buyer office · known for 70 of 70 awarded procedures · each procedure counts once

Greater London30 procedures · 43%
Scotland21 procedures · 30%
Wales (Cymru)10 procedures · 14%
North West England6 procedures · 9%
Northern Ireland3 procedures · 4%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 6 notices name this supplier, covering 7 lots since 6 Oct 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
7 of 7Lots on 6 notices: a place is won per lot.
Authorities bid for
i
1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health90%(97 awards)
    97 of 108 awards are NHS & health (90%).
  • Type not classified10%(11 awards)
    11 of 108 awards are Type not classified (10%).

Share = of the 70 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

89 of 110 awards carry an end date, 22 estimated from the duration · not a retender forecast

ContractEndsPublished value
Range Generic & Biosimilar Cancer Medicines (unranked)3 Jan 2027 estimated£1,714,852 ceiling
Generic Drugs - Tablets & Capsules31 Jan 2027£475,855
Wave 15b - Hospital Only (Housekeeping) All regions31 Jan 2027£1 ceiling
NP49425 Generic and Biosimilar Transition Medicines28 Feb 2027£64,103,740 ceiling
Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)28 Feb 2027£26,539,272 ceiling
Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products31 May 2027£17,727,000 ceiling
Lot 1 - CM/PHS/25/5728/0131 May 2027£688,834,174 ceiling
Medicinal Products - Direct to Trust2 Jun 2027 estimated£210,000,000 ceiling
Medicinal Products - with Pharma Funded Homecare Services2 Jun 2027 estimated£174,000,000 ceiling
Lot 1 - CM/TNS/25/572331 Aug 2027£150,085,000 ceiling

Soonest 10 of 12.

Recent awards

Latest 30 of 108 award records naming this supplier

Contracts Finder adds 2 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot published£665,389,588 †
framework ceiling · 1 of 24 appointed suppliers
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026NHS EnglandNot published£813,863,584 †
framework ceiling · 1 of 25 appointed suppliers
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£2,381,372 †
dynamic market estimate · not attributable revenue
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£236,800 †
dynamic market estimate · not attributable revenue
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£615,625 †
dynamic market estimate · not attributable revenue
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£64,103,740 †
framework ceiling · 1 of 31 appointed suppliers
Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£26,539,272 †
framework ceiling · 1 of 5 appointed suppliers
NP90425 Faricimab (Vabysmo®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£48,357,375 †
framework ceiling · not attributable revenue
NP90425 Faricimab (Vabysmo®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£48,357,375 †
framework ceiling · not attributable revenue
Trastuzumab and Rituximab SubcutThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£20,957,710 †
framework ceiling · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 67 of 110 awards, estimated from the published duration on 22 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.